Concepedia

Jan Martin

JM

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

2004

Affiliations

Cancer Research UK(Current)

Institute of Cancer Research

Jan Martin is an author at Cancer Research UK specializing in molecular oncology, oncology, and tumor-activated prodrugs.

Publications per year

2004–2008

6

Publications

6

B-RAF is a therapeutic target in melanoma

Maria Karasarides, Antonio Chiloeches, Robert Hayward et al. · Oncogene · 2004 · 433 citations

Medicine, Cancer Biology, Oncology +12

V599EB-RAF is an Oncogene in Melanocytes

Claudia Wellbrock, Lesley Ogilvie, Douglas Hedley et al. · Cancer Research · 2004 · 342 citations

Medicine, Cell Biology, Oncology +17

In Melanoma, <i>RAS</i> Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling

Nicolas Dumaz, Robert Hayward, Jan Martin et al. · Cancer Research · 2006 · 308 citations · Full text

Medicine, Cancer Biology, Oncology +17

Attenuated <i>Salmonella</i> Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy

Frank Friedlos, Panos Lehouritis, Lesley Ogilvie et al. · Clinical Cancer Research · 2008 · 90 citations · Full text

Pharmacy, Biotechnology, Oncology +14

A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

Astrid Mayer, Roslyn J. Francis, Surinder K. Sharma et al. · Clinical Cancer Research · 2006 · 80 citations

Pharmacy, Oncology, Pharmacology +17

1–5 of 6